维普期刊资源整合服务平台（V6.5）

289篇 您的检索式：作者名="Untch M"

选中清除导出查看参考文献查看引证文献引用追踪共15页首页上一页第1页下一页末页 /15 跳转

	题名	作者	年代	出处	被引量
1	Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinie acid 显示文摘	Hillemanns P Untch M Dannecker C	2000	Int J Cancer2000，85，5：	1
2	Photodynamie therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid 显示文摘	Hillemanns P Untch M Dannecker C	2000	Int J Cancer2000，85，5：	1
3	Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy(GeparQuinto,GBG 44):a randomised phase 3 trial显示文摘	Untch M Loibl S Bischoff J	2012	Lancet Oncol2012，13，2：	1
4	Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial显示文摘	Untch M Loibl S Bischoff J	2012	Lancet Oncol2012，13，2：	1
5	Re-challenging taxanes in recurrentbreast cancer in patients treated with (Neo-) adjuvant taxane-basedtherapy 显示文摘	Guo X Loibl S Untch M	2011	Breast Care (Basel)2011，6，4：	1
6	Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid显示文摘	Hillemanns P Untch M Prove F	1999	Obstet Gynecol1999，93，1：	1
7	Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer显示文摘	Konecny G Untch M Pihan A	2001	Clin Cancer Res2001，7，6：	1
8	Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid显示文摘	Hillemanns P Untch M Dannecker C	2000	Int J Cancer2000，85，5：	1
9	Minimal--invasive Biopsie und praoperative Markierung suspekter Mammalasionen 显示文摘	Sittek H Kessler M Untch M	2004	Gynakol Geburtshilfliche Rundsch2004，44，2：	1
10	Definition and impact of pathologic complete response on prognosis after neoad- juvant chemotherapy in various intrinsic breast cancer subtypes 显示文摘	von Minckwitz G Untch M Blohmer JU	2012	JClinOncol2012，30，15：	1
11	Impact of treat- ment characteristics on response of different breast cancer pheno- types:pooled analysis of the German neo adjuvant chemotherapy trials显示文摘	Von Minckwitz G Untch M Nuesch E	2011	Breast Cancer Res Treat2011，125，1：	1
12	Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial显示文摘	UNTCH M GELBER R D JACKISCH C	2008	Ann Oncol2008，19，6：	1
13	Pathological complete re- sponse and long-term clinical benefit in breast cancer: the CT- NeoBC pooled analysis显示文摘	Cortazar P Zhang L Untch M	2014	Lancet2014，384，9938：	1
14	Dose-dense sequential epirubicin paclitaxel as preoperative treatment of breast cancer: results of a randomized AGO study显示文摘	Untch M Konecny G Ditsch N	2002	Proc Am Soc Clin Oncol2002，21，：	1
15	Minimalasionen显示文摘	Sittk H Kessler M Untch M	2004	Gynakol Geb urtshilfiche Rundsch2004，44，2：	1
16	Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer显示文摘	Konecny G Untch M Pihan A	2001	Clin Cancer Res2001，7，6：	1
17	Her-2/neu and Urokinase-type plasminogen activatior and its inhibitor in breast cancer显示文摘	Konecny G Untch M Arboleda J	2001	Clin Cancer Res2001，7，8：	1
18	Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes显示文摘	yon Minckwitz G Untch M Blohmer JU	2012	J Clin Onco12012，30，15：	1
19	Chemosensitivity testing in gynecologic oncology-dream or reality显示文摘	Untch M Ditsch N LangerE		0，，02：	1
20	Association of urokinasetype plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer显示文摘	KONECNY G UNTCH M PIHAN A	2001	Clin Cancer Res2001，7，6：	1

返回顶部每页显示：

共15页首页上一页第1页下一页末页 /15 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示